Apr 23
|
Novo Nordisk (NVO) Boasts Earnings & Price Momentum: Should You Buy?
|
Apr 22
|
Why Novo Nordisk Topped the Market Today
|
Apr 22
|
Lilly to buy injectable drug plant in manufacturing ramp-up
|
Apr 20
|
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
|
Apr 20
|
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
|
Apr 20
|
3 Relatively Safe Growth Stocks You Can Buy and Hold
|
Apr 19
|
Weight loss drugs and the many use cases in medical treatments
|
Apr 19
|
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
|
Apr 9
|
Meet Europe’s Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.
|
Apr 9
|
Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up
|
Apr 9
|
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
|
Apr 8
|
Weight-loss drug shortage result of 'unprecedented demand'
|
Apr 8
|
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond
|
Apr 8
|
UPDATE 1-EU regulator to review reports of suicidal thoughts and weight loss drugs
|
Apr 8
|
Novo Nordisk parent refiles US application on Catalent deal
|
Apr 8
|
UPDATE 1-Novo Nordisk parent refiles US application on Catalent deal
|
Apr 8
|
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
|
Apr 7
|
Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
Apr 6
|
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
|